The role of vascular aging in atherosclerosis

doi:10.16352/j.issn.1001-6325.2022.03.033

Abstract

Abstract: Vascular aging is an age-dependent degeneration of vascular structure and function, which can lead to an increased risk of cardiovascular diseases. Atherosclerosis is an essential pathogenesis of cardiovascular diseases. Vascular aging plays an important role in the progression of atherosclerosis. Effective evaluation of vascular aging is necessary for the clinical treatment of atherosclerotic diseases. This review summarized the structural and functional changes of vascular aging, and highlighted the important roles of telomere attrition, mitochondrial dysfunction and inflammation of vascular cells in the process of atherosclerosis, aiming to provide new impetus for the clinical treatment of atherosclerotic diseases.

Key words: vascular aging, atherosclerosis, telomere attrition, mitochondrial dysfunction, inflammation

CLC Number:

R654.3

ZHANG Qi-yue, ZHANG Wei-li. The role of vascular aging in atherosclerosis[J]. Basic & Clinical Medicine, 2022, 42(3): 372-377.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.03.033

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I3/372

References

[1]中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36: 521-545.
[2]JOAKIMSEN O, BONAA KH, STENSLAND-BUGGE E, et al. Age and sex differences in the distribution and ultrasound morphology of carotid atherosclerosis: the Tromsø Study[J]. Arterioscler Thromb Vasc Biol, 1999, 19: 3007-3013.
[3]IURCIUC S, CIMPEAN AM, MITU F, et al. Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology?[J]. Clin Interv Aging, 2017, 12: 1339-1345.
[4]FRISMANTIENE A, PHILIPPOVA M, ERNE P, et al. Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity[J]. Cell Signal, 2018, 52: 48-64.
[5]LAKATTA EG, LEVY D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease[J]. Circulation, 2003, 107: 139-146.
[6]SALONEN JT, SALONEN R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression[J]. Circulation, 1993, 87: 1156-1165.
[7]KARIKKINETH AC, ALGHATRIF M, OBERDIER MT, et al. Sex differences in longitudinal determinants of carotid intima medial thickening with aging in a com-munity-dwelling population: the Baltimore longitudinal study on aging[J]. J Am Heart Assoc, 2020, 9: e015396.doi: 10.1161/JAHA.119.015396.
[8]TAKEMURA A, IIJIMA K, OUCHI Y. Molecular mechanism of vascular aging: impact of vascular smooth muscle cell calcification via cellular senescence[J]. Clin Calcium, 2010, 20: 1646-1655.
[9]VLACHOPOULOS C, AZNAOURIDIS K, STEFANADIS C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis[J]. J Am Coll Cardiol, 2010, 55: 1318-1327.
[10]FRITZE O, ROMERO B, SCHLEICHER M, et al. Age-related changes in the elastic tissue of the human aorta[J]. J Vasc Res, 2012, 49: 77-86.
[11]SEDAGHAT S, VAN SLOTEN TT, LAURENT S, et al. Common carotid artery diameter and risk of cardiovascular events and mortality: pooled analyses of four cohort studies[J]. Hypertension, 2018, 72: 85-92.
[12]VANHOUTTE PM, MOMBOULI JV. Vascular endothelium: vasoactive mediators[J]. Progress in cardiovascular diseases, 1996, 39: 229-238.
[13]MINAMINO T, MIYAUCHI H, YOSHIDA T, et al. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction[J]. Circulation, 2002, 105: 1541-1544.
[14]QIAN J, FULTON D. Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium[J]. Front Physiol, 2013, 4: 347.doi: 10.3389/fphys.2013.00347.
[15]BHANDARI SS, DAVIES JE, STRUCK J, et al. Plasma C-terminal proEndothelin-1 (CTproET-1) is affected by age, renal function, left atrial size and diastolic blood pressure in healthy subjects[J]. Peptides, 2014, 52: 53-57.
[16]DONATO AJ, GANO LB, ESKURZA I, et al. Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase[J]. Am J Physiol Heart Circ Physiol, 2009, 297: H425-432.
[17]JANKOWICH MD, WU WC, CHOUDHARY G. Association of elevated plasma endothelin-1 levels with pulmonary hypertension, mortality, and heart failure in African American individuals: The Jackson Heart Study[J]. JAMA Cardiol, 2016, 1: 461-469.
[18]O'DONNELL CJ, DEMISSIE S, KIMURA M, et al. Leukocyte telomere length and carotid artery intimal medial thickness: the Framingham Heart Study[J]. Arterioscler Thromb Vasc Biol, 2008, 28: 1165-1171.
[19]ZHANG W, CHEN Y, WANG Y, et al. Short telomere length in blood leucocytes contributes to the presence of atherothrombotic stroke and haemorrhagic stroke and risk of post-stroke death[J]. Clin Sci (Lond), 2013, 125: 27-36.
[20]AVIV A. Genetics of leukocyte telomere length and its role in atherosclerosis[J]. Mutat Res, 2012, 730: 68-74.
[21]VASILEIOU PVS, EVANGELOU K, VLASIS K, et al. Mitochondrial homeostasis and cellular senescence[J]. Cells, 2019, 8: 686. doi: 10.3390/cells8070686.
[22]FOOTE K, REINHOLD J, YU EPK, et al. Restoring mitochondrial DNA copy number preserves mitochondrial function and delays vascular aging in mice[J]. Aging Cell, 2018, 17: e12773.doi: 10.1111/acel.12773.
[23]YU EPK, REINHOLD J, YU H, et al. Mitochondrial respiration is reduced in atherosclerosis, promoting necrotic core formation and reducing relative fibrous cap thickness[J]. Arterioscler Thromb Vasc Biol, 2017, 37: 2322-2332.
[24]DI MICCO R, KRIZHANOVSKY V, BAKER D, et al. Cellular senescence in ageing: from mechanisms to therapeutic opportunities[J]. Nat Rev Mol Cell Biol, 2021, 22: 75-95.
[25]COPPé JP, PATIL CK, RODIER F, et al. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen[J]. PLoS One, 2010, 5: e9188.doi: 10.1371/journal.pone.0009188.
[26]WOLF D, LEY K. Immunity and Inflammation in Atherosclerosis[J]. Circ Res, 2019, 124: 315-327.
[27]SONG Y, SHEN H, SCHENTEN D, et al. Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells[J]. Arterioscler Thromb Vasc Biol, 2012, 32: 103-109.
[28]MADAN M, BISHAYI B, HOGE M, et al. Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model[J]. Atherosclerosis, 2008, 197: 504-514.
[29]FERRANTE G, CONDORELLI G. Interleukin-6 trans-signalling and risk of future cardiovascular events: a new avenue for atheroprotection?[J]. Cardiovasc Res, 2019, 115: 8-9.
[30]ASHOR AW, LARA J, SIERVO M, et al. Exercise modalities and endothelial function: a systematic review and dose-response meta-analysis of randomized controlled trials[J]. Sports Med, 2015, 45: 279-296.
[31]GREEN DJ, SMITH KJ. Effects of exercise on vascular function, structure, and health in humans[J]. Cold Spring Harb Perspect Med, 2018, 8: a029819. doi:10.1101/cshperspect.a029819.
[32]DURRANT JR, SEALS DR, CONNELL ML, et al. Voluntary wheel running restores endothelial function in conduit arteries of old mice: direct evidence for reduced oxidative stress, increased superoxide dismutase activity and down-regulation of NADPH oxidase[J]. J Physiol, 2009, 587: 3271-3285.
[32]LAROCCA TJ, MARTENS CR, SEALS DR. Nutrition and other lifestyle influences on arterial aging[J]. Ageing Res Rev, 2017, 39: 106-119.
[33]GROOTAERT MOJ, FINIGAN A, FIGG NL, et al. SIRT6 protects smooth muscle cells from senescence and reduces atherosclerosis[J]. Circ Res, 2021, 128: 474-491.
[34]HICKSON LJ, LANGHI PRATA LGP, BOBART SA, et al. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease[J]. E Bio Medicine, 2019, 47: 446-456.